AnodyneWiki

Remifentanil

Remifentanil
Remifentanil
Salts
[]
Remifentanil hydrochloride
Remifentanil hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass376.40 g/mol [1]
AppearanceOil [1]
Melting pointCrystals from methanol + ether. MP: 212-214 °C /Remifentanil hydrochloride/ [1]
SolubilitySoluble in methanol, ethyl acetate [1]
Predicted LogP1.9 [1]
Structural Identifiers
[]
Molecular formulaC20H28N2O5
IUPAC namemethyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
SMILESCCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
InChIInChI=1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3
InChIKeyZTVQQQVZCWLTDF-UHFFFAOYSA-N
CAS number132875-61-7
UNIIP10582JYYK
PubChem CID60815
Pharmacokinetics[]
Elimination half-life1-20 minutes
Metabolismcleaved by non-specific plasma and tissue esterases
Routes of administrationIntravenous

Remifentanil (also known as Remifentanyl, ramifentanyl, Gi 87084x, Ultiva-, Remifentanilo, Ids-nr-005, 4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester, methyl 1-(3-methoxy-3-oxopropyl)-4-(N-phenylpropanamido)piperidine-4-carboxylate, remifentanilum or N01ah06) is a opioid substance of the aniline and amino acid class.

Chemistry

Salts []

Remifentanil is typically found in the form of its hydrochloride salt.

 []

Remifentanil is achiral.

Remifentanil matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Remifentanil is a µ-opioid agonist with rapid onset and peak effect, and short duration of action. The µ-opioid activity of remifentanil is antagonized by opioid antagonists such as naloxone. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

shared target123 (2 contraindicated)

Medical side effects []

134 side effects listed on drug labels in (remifentanil).

  • Nausea
  • Pain
  • Ache
  • Vomiting
  • Confusional state
  • Feeling abnormal
  • Procedural hypertension
  • Post procedural complication
  • Postoperative complications NOS
  • Pleural effusion
  • Hyperhidrosis
  • Hypotension
  • Hypotensive
  • Constipation
  • Anxiety
  • Atrial fibrillation
  • Chills
  • Shivering
  • Diarrhoea
  • Post procedural infection
  • Hypertension
  • Pruritus
  • Bradycardia
  • Respiratory depression
  • Pulmonary function test decreased
  • Oedema
  • Dizziness
  • Syncope
  • Pneumonia
  • Muscle rigidity
  • Hallucination
  • Dyspepsia
  • Pharyngitis
  • Myocardial ischaemia
  • Apnoea
  • Cerebral infarction
  • Headache
  • Agitation
  • Atelectasis
  • Pneumothorax
  • Hyperkalaemia
  • Paraesthesia
  • Convulsion
  • Urinary retention
  • Respiratory distress
  • Tachycardia
  • Flushing
  • Body temperature increased
  • Atrial flutter
  • Dyspnoea
  • Haematuria
  • Sleep disorder
  • Cerebral ischaemia
  • Hypoxia
  • Bronchospasm
  • Pulmonary oedema
  • Ventricular extrasystoles
  • Renal failure
  • Renal impairment
  • Anaemia
  • Haemorrhage
  • Haemoglobin
  • Ventricular fibrillation
  • Cardiac output decreased
  • Procedural pain
  • Anaphylactic shock
  • Cardiac arrest
  • Hypersensitivity
  • Amnesia
  • Arrhythmia
  • Coagulopathy
  • Bronchitis
  • Cough
  • Dysphagia
  • Dysuria
  • Dermatitis
  • Rash
  • Gastrooesophageal reflux disease
  • Gastrointestinal disorder
  • Atrioventricular block
  • Cardiac disorder
  • Haemoptysis
  • Hiccups
  • Hyperglycaemia
  • Hypokalaemia
  • Body temperature decreased
  • Hypothermia
  • Immune system disorder
  • Laryngospasm
  • Leukocytosis
  • Lymphopenia
  • Mediastinal disorder
  • Nasal congestion
  • Nervous system disorder
  • Nightmare
  • Nystagmus
  • Oliguria
  • Pericarditis
  • Rales
  • Rhonchi
  • Shock
  • Stridor
  • Loss of consciousness
  • Thrombocytopenia
  • Tremor
  • Erythema
  • Urinary incontinence
  • Urticaria
  • Angiopathy
  • Dry mouth
  • Ventricular arrhythmia
  • Atrioventricular block first degree
  • Hepatic function abnormal
  • Atrioventricular block complete
  • Blood creatine phosphokinase increased
  • Skin disorder
  • Musculoskeletal stiffness
  • Muscle twitching
  • Abdominal discomfort
  • Disorientation
  • Dysphoria
  • Pulmonary congestion
  • Respiratory tract congestion
  • Dyskinesia
  • Musculoskeletal chest pain
  • Visual impairment
  • Electrocardiogram change
  • Infusion site reaction
  • Ileus
  • Nasopharyngitis
  • Rhinorrhoea
  • Haematochezia
  • Electrolyte imbalance
  • Somnolence

Subjective effects []

bonzi / Remifentanil []
vivi / Remifentanil []
Routes:
  • Intravenous (560.0µg)

 []

  • Australia: Remifentanil is a Schedule 8.
  • Brazil: Remifentanil is a A1.[3]
  • Canada: Remifentanil is a Schedule I.
  • Germany: Remifentanil is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
  • United Kingdom: Remifentanil is a Class A under the "Misuse of Drugs Act 1971".
  • United States: Remifentanil is a Schedule II under the "Controlled Substances Act".
  • Other: Remifentanil is a SE: Förteckning II.[4]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 60815, Remifentanil. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/60815
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Remifentanil. UNII: P10582JYYK. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/P10582JYYK
  3. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  4. Remifentanil hameln, Pulver till koncentrat till injektions-/infusionsvätska, lösning 1 mg. FASS. 16 March 2026. https://fass.se/health/product/20210705000012/fass-text

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 16:59:33
drugspromissing (no DrugsPRO reagent data)2026-11-20 16:59:29
erowidmissing (no Erowid substance of that name)2026-11-20 16:59:29
gsrsok2026-11-20 16:59:30
hmdbmissing (hmdb.ca refused automated access to HMDB0015036)2026-11-20 16:59:29
keggok2026-11-20 16:59:32
pubchemok2026-11-20 16:59:28
redditmissing (no r/tripreports posts mention it)2026-11-20 16:59:28
siderok2026-11-20 16:59:29
structureok2026-11-20 16:59:28
wikipediaok2026-11-20 16:59:29